Selling your pharmacy or finding an equity partner is a major decision. Timing is important. So are market conditions, the regulatory environment, and tax implications. Choosing the right advisor to assist you can make a substantial difference in the value of your pharmacy, the structure of the deal and your overall flexibility after the sale. Harbor has successfully closed more than $1 billion in transactions for pharmacy owners since 1996. We understand the market, we listen to your goals and we use that knowledge to negotiate the best deal on your behalf.
Harbor represents clients in the Long Term Care (LTC), Specialty, Infusion and Compounding sectors of pharmacy. Unlike our competitors, Harbor does not represent other healthcare entities. Pharmacy is our arena and we understand the market better than anyone. Harbor is pharmacist-owned and our team includes pharmacists, pharmacy operations executives and financial advisors who are skilled in healthcare transactions. We have a combined knowledge of more than 100 years in the industry and we use this knowledge to guide you throughout the process. We consult with you to determine your goals and expectations. Harbor seeks to understand your specific business model and the factors that make it unique. We use this knowledge to position your pharmacy with prospective buyers while our financial team reviews your financial data to ensure that you receive the highest valuation for your business.
Pharmacy Services
(Long Term Care, Specialty, Home Infusion, Compounding).
Clinical Research Organization
Digital Health
Cannabis
Behavioral Health
Ira Cammeyer and the Harbor Healthcare team have been a trusted advisor for all the Modern Health companies. Over the course of more than 15 years, Harbor has represented Modern in its acquisition strategy, along with its recent final sale of certain operating assets of its successful long-term care division. Harbor handled all transactions in the most professional and sensitive manner. In all our transactions, Ira and the team have been a valued member of Modern’s transaction/transition planning.
Modern Health Holdings
Richard Katz
This year is a dynamic and fast-paced one for compounding pharmacy M&A. Early in the year, unpredictability in the broader[...]
More
LTC Pharmacy underwent more disruption and change in just the past few years than the preceding decades. Revenue models morphed,[...]
More
The healthcare services sector continues to attract attention from buyers across a broad range of backgrounds. While late 2021 and[...]
More